See every side of every news story
Published loading...Updated

Tenecteplase in the Extended Time Window

Summary by Eso-stroke.org
.flex_column.av-pxfofs-f8cffa300d0abe60229a0238b37e998b{ border-radius:0px 0px 0px 0px; padding:0px 0px 0px 0px; } 24/01/2025/in ESO, Stroke Research /by Carine Legio Author: Vojtech Novotny X: @vojtech_no The pharmacokinetics and pharmacodynamics of tenecteplase have been proven superior to alteplase, and it has been used for myocardial infarction for over 25 years.¹ However, the adoption of tenecteplase as a thrombolytic for acute ischemic str…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

eso-stroke.org broke the news in on Friday, January 24, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.